Inferra AI / Company / AME
Ametek
AME · Industrials
Last earnings Aug 4, 2026 · Next earnings Nov 3, 2026
Key results
Operating incomequarter
3%
Operating income increased 3% to $461.6 million and operating margins were up 20 basis points to 26.0% versus the prior year.
SEC original ↗Ametek — Earnings release (8-K exhibit)EX-99Jul 31, 2025
Operating income was $344.4 million in the quarter with operating income margins a very strong 29.7%.
SEC original ↗Ametek — Earnings release (8-K exhibit)EX-99Jul 31, 2025
EMG s second quarter operating income was up 17% to a record $143.9 million, and operating income margins were up 210 basis points to 23.3% in the quarter versus the prior year s results.
SEC original ↗Ametek — Earnings release (8-K exhibit)EX-99Jul 31, 2025
AI analysis
Q2 2025 · reported Jul 31, 2025
Based on: Earnings release + parent 8-K + 10-Q — transcript not held
Guidance · company-stated
Direction: Raised
“This is an increase from our previous guidance range of $7.02 to $7.18, he added.”
Classified from the release's primary full-year outlook statement.
Capital allocation
Improvements include changes to similar risk assessment for cash flow hedges, a new model for Choose-Your-Rate debt instruments, a principles-based approach for nonfinancial forecasted transactions, clarification on net written options, and addressing the mismatch in dual-hedge accounting.
The Company s net long-term debt is all privately held with no public market for this debt, therefore, the fair value of net long-term debt was computed based on comparable current market data for similar debt instruments and is considered a level 3 liability.
Event summary
AMETEK Announces Record Second Quarter Results and Raises Full Year Guidance
Based on: Earnings release + parent 8-K + 10-Q — transcript not held
Guidance & outlook
Direction: Raised
Company outlook: “This is an increase from our previous guidance range of $7.02 to $7.18, he added.”
Company outlook — Raised (“Raises”)
“htm EX-99.1 Document Exhibit 99.1 AMETEK Announces Record Second Quarter Results and Raises Full Year Guidance Berwyn, Pa.”
Company outlook — Raised (“raised”)
“Given our results in the second quarter and the acquisition of FARO Technologies, we have raised our full year earnings guidance.”
Company outlook — Raised (“increase”)
“This is an increase from our previous guidance range of $7.02 to $7.18, he added.”
Classified from the release's primary full-year outlook statement.
Capital allocation
Improvements include changes to similar risk assessment for cash flow hedges, a new model for Choose-Your-Rate debt instruments, a principles-based approach for nonfinancial forecasted transactions, clarification on net written options, and addressing the mismatch in dual-hedge accounting.
SEC original ↗Ametek — 10-Q Quarterly report10-QAug 4, 2026
The Company s net long-term debt is all privately held with no public market for this debt, therefore, the fair value of net long-term debt was computed based on comparable current market data for similar debt instruments and is considered a level 3 liability.
SEC original ↗Ametek — 10-Q Quarterly report10-QAug 4, 2026
Hedging Activities The Company has designated certain foreign-currency-denominated long-term borrowings as hedges of the net investment in certain foreign operations.
SEC original ↗Ametek — 10-Q Quarterly report10-QAug 4, 2026
As of June 30, 2026, these net investment hedges included British-pound and Euro-denominated long-term debt.
SEC original ↗Ametek — 10-Q Quarterly report10-QAug 4, 2026
These borrowings were designed to create net investment hedges in certain designated foreign subsidiaries.
SEC original ↗Ametek — 10-Q Quarterly report10-QAug 4, 2026
Any gain or loss on the hedging instruments (the debt) following hedge designation is reported in accumulated other comprehensive income in the same manner as the translation adjustment on the hedged investment based on changes in the spot rate, which is used to measure hedge effectiveness.
SEC original ↗Ametek — 10-Q Quarterly report10-QAug 4, 2026
Strategy & priorities
I was pleased with our results in the quarter as we delivered record sales and EBITDA, strong earnings growth, and excellent core margin expansion against the backdrop of a sluggish and uncertain economic environment, commented David A.
SEC original ↗Ametek — Earnings release (8-K exhibit)EX-99Jul 31, 2025
Page 1 EMG had an excellent quarter highlighted by strong organic sale s and orders growth, record-level operating income and robust margin expansion.
SEC original ↗Ametek — Earnings release (8-K exhibit)EX-99Jul 31, 2025
AMETEK s flexible and resilient operating structure positions us well to successfully manage through this uncertainty and deliver strong margin expansion and earnings growth, commented Mr.
SEC original ↗Ametek — Earnings release (8-K exhibit)EX-99Jul 31, 2025
Additionally, our strong cash generation and balance sheet provide us meaningful capital to deploy on strategic acquisitions and growth initiatives.
SEC original ↗Ametek — Earnings release (8-K exhibit)EX-99Jul 31, 2025
The AMETEK Growth Model integrates the Four Growth Strategies - Operational Excellence, Technology Innovation, Global and Market Expansion, and Strategic Acquisitions - with a disciplined focus on cash generation and capital deployment.
SEC original ↗Ametek — Earnings release (8-K exhibit)EX-99Jul 31, 2025
Risks & headwinds
We continue to see customer uncertainty and slower decision making given the global trade challenges.
SEC original ↗Ametek — Earnings release (8-K exhibit)EX-99Jul 31, 2025
2025 Outlook Our businesses delivered strong operating results in the quarter despite the impact of the on-going trade uncertainty.
SEC original ↗Ametek — Earnings release (8-K exhibit)EX-99Jul 31, 2025
AMETEK s flexible and resilient operating structure positions us well to successfully manage through this uncertainty and deliver strong margin expansion and earnings growth, commented Mr.
SEC original ↗Ametek — Earnings release (8-K exhibit)EX-99Jul 31, 2025
Forward-looking statements are subject to various factors and uncertainties that may cause actual results to differ materially from expectations.
SEC original ↗Ametek — Earnings release (8-K exhibit)EX-99Jul 31, 2025
Contingencies Asbestos Litigation The Company (including its subsidiaries) has been named as a defendant in a number of asbestos-related lawsuits.
SEC original ↗Ametek — 10-Q Quarterly report10-QAug 4, 2026
Certain of these lawsuits relate to a business which was acquired by the Company and do not involve products which were manufactured or sold by the Company.
SEC original ↗Ametek — 10-Q Quarterly report10-QAug 4, 2026
Earnings deck slides
0 decks with slide viewAmetek — Presentation / slide deck (8-K exhibit) — Slide view unavailable — this deck was filed as a web document, whose text has no page boundaries.
Ametek — Presentation / slide deck (8-K exhibit) — Slide view unavailable — this deck was filed as a web document, whose text has no page boundaries.
Ametek — Presentation / slide deck (8-K exhibit) — Slide view unavailable — this deck was filed as a web document, whose text has no page boundaries.
Competitors
Competitors & peers
Same GICS sector — classification peers, not declared competitors
Filings
71 documents- Q2 2026
- 8-KAME
Aug 26, 2026
- 8-KAME
Aug 11, 2026
- 10-QAME
Aug 4, 2026
- 8-KAME
Aug 4, 2026
- Q1 2026
- 8-KAME
Jun 12, 2026
- 8-KAME
May 26, 2026
- 8-KAME
May 11, 2026
- 8-KAME
May 8, 2026
- 8-KAME
May 6, 2026
- 10-QAME
Apr 30, 2026
- 8-KAME
Apr 30, 2026
- EX-99AME
Apr 30, 2026
- Q4 2025
- 10-KAME
Feb 17, 2026
- 8-KAME
Feb 12, 2026
- 8-KAME
Feb 3, 2026
- EX-99AME
Feb 3, 2026
- Q3 2025
- 8-KAME
Nov 10, 2025
- 10-QAME
Oct 30, 2025
- 8-KAME
Oct 30, 2025
- EX-99AME
Oct 30, 2025
- Q2 2025
- 10-QAME
Jul 31, 2025
- 8-KAME
Jul 31, 2025
- 8-KAME
Jul 21, 2025
- Q1 2025
- 8-KAME
May 8, 2025
- 8-KAME
May 8, 2025
- 10-QAME
May 1, 2025
- 8-KAME
May 1, 2025
- Q4 2024
- 10-KAME
Feb 20, 2025
- 8-KAME
Feb 10, 2025
- 8-KAME
Feb 4, 2025
- EX-99AME
Feb 4, 2025
- 8-KAME
Jan 6, 2025
- Q3 2024
- 10-QAME
Oct 31, 2024
- 8-KAME
Oct 31, 2024
- EX-99AME
Oct 31, 2024
- Q2 2024
- 8-KAME
Aug 1, 2024
- EX-99AME
Aug 1, 2024
- 10-QAME
Aug 1, 2024
- Q1 2024
- 8-KAME
May 8, 2024
- 8-KAME
May 2, 2024
- EX-99AME
May 2, 2024
- 10-QAME
May 2, 2024
- Q4 2023
- 10-KAME
Feb 22, 2024
- 8-KAME
Feb 9, 2024
- 8-KAME
Feb 6, 2024
- 8-KAME
Jan 16, 2024
- Q3 2023
- 8-KAME
Dec 11, 2023
- 8-KAME
Oct 31, 2023
- 10-QAME
Oct 31, 2023
- EX-99AME
Oct 31, 2023
- EX-99AME
Oct 31, 2023
- Q2 2023
- 8-KAME
Sep 7, 2023
- 8-KAME
Aug 1, 2023
- 10-QAME
Aug 1, 2023
- Q1 2023
- 8-KAME
May 8, 2023
- 8-KAME
May 2, 2023
- 10-QAME
May 2, 2023
- EX-99AME
May 2, 2023
- Q4 2022
- 10-KAME
Feb 21, 2023
- 8-KAME
Feb 10, 2023
- 8-KAME
Feb 2, 2023
- Q3 2022
- 8-KAME
Nov 1, 2022
- 10-QAME
Nov 1, 2022
- EX-99AME
Nov 1, 2022
- Q2 2022
- 8-KAME
Aug 8, 2022
- 8-KAME
Aug 2, 2022
- 10-QAME
Aug 2, 2022
- Q1 2022
- 8-KAME
May 16, 2022
- 8-KAME
May 6, 2022
- 8-KAME
May 3, 2022
- 10-QAME
May 3, 2022
Earnings releases
19 documents- Q2 2026
- EX-99AME
Aug 26, 2026
- EX-99AME
Aug 4, 2026
- Q1 2026
- EX-99AME
May 26, 2026
- EX-99AME
May 8, 2026
- EX-99AME
May 6, 2026
- EX-99AME
Apr 30, 2026
- Q4 2025
- EX-99AME
Feb 12, 2026
- EX-99AME
Feb 3, 2026
- Q3 2025
- EX-99AME
Nov 10, 2025
- Q2 2025
- EX-99AME
Jul 31, 2025
- Q3 2024
- EX-99AME
Oct 31, 2024
- Q4 2023
- EX-99AME
Feb 6, 2024
- Q3 2023
- EX-99AME
Oct 31, 2023
- Q2 2023
- EX-99AME
Aug 1, 2023
- Q1 2023
- EX-99AME
May 2, 2023
- Q4 2022
- EX-99AME
Feb 2, 2023
- Q3 2022
- EX-99AME
Nov 1, 2022
- Q2 2022
- EX-99AME
Aug 2, 2022
- Q1 2022
- EX-99AME
May 3, 2022
Presentations
3 documentsTranscripts
0 documentsNo transcripts for Ametek are held in this edition of the library.
Mentioned by
5 companiesOther tracked companies whose held documents mention Ametek by name or ticker. A mention is counted once per document, from the document text the library holds.
“to extend this well beyond that horizon. 19 At the time of the merger with Randgold, the AME region had two Tier One mines. The newly proposed expansion that forms the core… …its historically consistent performance by meeting its production guidance”
“res 229,086 230,818 228,994 230,743 Dividends per share $ 0.34 $ 0.31 $ 0.68 $ 0.62 AMETEK, Inc. Information by Business Segment (In thousands)… … on cash generation and capital deployment. AMETEK's objective is double-digit percentage growth i”
“obal audit, and supply chain finance at Astra Zeneca Pharmaceuticals, AET Films, Inc. and Ametek, Inc. Mr. DelOrefice is a Certified…”
British American Tobacco (BTI)
“ Group's Indian associate ITC (see page 32 ). These were… …by the U.S. and AME – Reported profit from operations up 265% (with reported operating margin up 28.4 ppts to 39.0%), largely due to the movement in the”
“look for region remains robust 1) Percentages refer to 2018 EBITDA before eliminations of AME&A Philippines… …products; weather conditions including disasters such as earthquakes and floods; trade barriers, including tariffs or import taxes and chang”
See also the earnings calendar for every tracked company’s next earnings date.